Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$382000.0.

  • CV Sciences' Income from Continuing Operations rose 1622.81% to -$382000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 4165.02%. This contributed to the annual value of -$2.4 million for FY2024, which is 17707.66% down from last year.
  • Per CV Sciences' latest filing, its Income from Continuing Operations stood at -$382000.0 for Q3 2025, which was up 1622.81% from -$261000.0 recorded in Q2 2025.
  • CV Sciences' Income from Continuing Operations' 5-year high stood at $5.7 million during Q1 2023, with a 5-year trough of -$8.9 million in Q4 2021.
  • Over the past 5 years, CV Sciences' median Income from Continuing Operations value was -$726000.0 (recorded in 2024), while the average stood at -$1.2 million.
  • Per our database at Business Quant, CV Sciences' Income from Continuing Operations plummeted by 247750.0% in 2022 and then skyrocketed by 47663.37% in 2023.
  • Over the past 5 years, CV Sciences' Income from Continuing Operations (Quarter) stood at -$8.9 million in 2021, then skyrocketed by 73.89% to -$2.3 million in 2022, then skyrocketed by 62.6% to -$865000.0 in 2023, then increased by 16.07% to -$726000.0 in 2024, then skyrocketed by 47.38% to -$382000.0 in 2025.
  • Its Income from Continuing Operations was -$382000.0 in Q3 2025, compared to -$261000.0 in Q2 2025 and -$109000.0 in Q1 2025.